1
TITLE: Brolucizumab 12-and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials
AUTHORS: Singer, Michael; Khanani, Arshad M.; Wolf, Armin; Flores, Rita; Chhablani, Jay; Guruprasad, B.; Clemens, Andreas; Gedif, Kinfemichael; Liu, Xiaoxi; Mulyukov, Zufar; Querques, Giuseppe;
PUBLISHED: 2022, SOURCE: OPHTHALMOLOGICA, VOLUME: 245, ISSUE: 4
INDEXED IN: Scopus WOS